Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients

Annals of Surgery

Volumn 254, Issue 1, 2011, Pages 119-124

  Wagner, Jamie L ^a   Warneke, Carla L ^a   Mittendorf, Elizabeth A ^a   Bedrosian, Isabelle ^a   Babiera, Gildy V ^a   Kuerer, Henry M ^a   Hunt, Kelly K ^a   Yang, Wei ^a   Sahin, Aysegul A ^a   Meric Bernstam, Funda ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INHIBITION; CANCER INVASION; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; PARTIAL MASTECTOMY; PLASTIC SURGERY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; THERAPY DELAY; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 79959520494     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318217e97f     Document Type: Article

References (24)

1. Smith BD, Smith GL, Hurria A, et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27(17):2758-2765.
2. Weedon-Fekjaer H, Lindqvist BH, Vatten LJ, et al. Breast cancer tumor growth estimated through mammography screening data. Breast Cancer Res. 2008;10(3):R41.
3. McCahill LE, Privette A, James T, et al. Quality measures for breast cancer surgery: initial validation of feasibility and assessment of variation among surgeons. Arch Surg. 2009;144(5):455-462; discussion 462-453.
4. National Quality Measures for Breast Centers™ A Quality Initiative of the National Consortium of Breast Centers, Inc. Website. Available at: http://www.nqmbc.org/List-of-all-NQMBC-Measures.pdf. Accessed February 13, 2010
5. Lancaster T. Guidance on cancer services improving outcomes in breast cancer. August 2002. National Institute for Clinical Excellence Copyright. Available at: http://www.nice.org.uk/nicemedia/pdf/Improving-outcomes- breastcancer-manual.pdf. Accessed February 13, 2010.
6. Department of Health. HSC 1998/1242: Breast cancer waiting times achieving the two week target. December 1922, 1998. Crown Copyright. Available at: http://www.dh.gov.uk/prod-consum-dh/groups/dh-digitalassets/@dh/@en/ documents/digitalasset/dh-4011903.pdf. Accessed February 13, 2010.
7. Bardell T, Belliveau P, Kong W, Mackillop WJ, et al. Waiting times for cancer surgery in Ontario: 1984-2000. Clin Oncol (R Coll Radiol). 2006;18(5):401-409.
8. Reed AD, Williams RJ, Wall PA, Hasselback P, et al. Waiting time for breast cancer treatment in Alberta. Can J Public Health. 2004;95(5):341-345. (Pubitemid 39328277)
9. Williams TE Jr, Satiani B, Thomas A, et al. The impending shortage and the estimated cost of training the future surgical workforce. Ann Surg. 2009;27.
10. Montella M, Crispo A, D'Aiuto G, et al. Determinant factors for diagnostic delay in operable breast cancer patients. Eur J Cancer Prev. 2001;10(1):53-59. (Pubitemid 32200202)
11. Hershman DL, Wang X, McBride R, et al. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat. 2006;99(3):313-321. (Pubitemid 44337924)
12. Chevray PM. Timing of breast reconstruction: immediate versus delayed. Cancer J. 2008;14(4):223-229.
13. Richards MA, Westcombe AM, Love SB, et al. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353(9159): 1119-1126. (Pubitemid 29155203)
14. Richards MA, Smith P, Ramirez AJ, et al. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer. 1999;79(5-6):858-864. (Pubitemid 29082117)
15. Vujovic O, Perera F, Dar AR, et al. Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence? Int J Radiat Oncol Biol Phys. 1998;40(4): 869-874. (Pubitemid 28150805)
16. Huang J, Barbera L, Brouwers M, et al. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol. 2003;21(3):555-563. (Pubitemid 46606487)
17. Yiangou C, Shousha S, Sinnett HD. Primary tumour characteristics and axillary lymph node status in breast cancer. Br J Cancer. 1999;80(12):1974-1978. (Pubitemid 29391283)
18. Brenin DR, Manasseh DM, El-Tamer M, et al. Factors correlating with lymph node metastases in patients with T1 breast cancer. Ann Surg Oncol. 2001;8(5):432-437. (Pubitemid 32524767)
19. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer. 1997;79(10): 1918-1922. (Pubitemid 27200375)
20. Theodosiou Z, Kasampalidis IN, Karayannopoulou G, et al. Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases. Breast. 2008;17(1):80-84. (Pubitemid 351228789)
21. Golshan M, Fung BB, Wiley E, et al. Prediction of breast cancer size by ultrasound, mammography and core biopsy. Breast. 2004;13(4):265-271. (Pubitemid 39172725)
22. Wasif N, Garreau J, Terando A, et al. MRI versus ultrasonography and mammography for preoperative assessment of breast cancer. Am Surg. 2009;75(10):970-975.
23. Kuhl C, Kuhn W, Braun M, et al. Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back? Breast. 2007;16(Suppl 2): S34-44.
24. Bleicher RJ, Ciocca RM, Egleston BL, et al. Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg. 2009;209(2):180-187; quiz 294-185.